临床与MRI特征鉴别非肝硬化慢性HBV患者反应性淋巴增生与肝细胞癌
本研究回顾性纳入31例病理确诊的肝脏反应性淋巴增生(RLH)患者和31例倾向性评分匹配的肝细胞癌(HCC)患者,比较临床与MRI特征。低AFP、边界不清、T2WI病灶周围高信号是RLH的独立预测特征,联合模型AUC达0.965,敏感度96.8%,特异度83.9%,显著优于单一指标。
要点
- 低AFP、边界不清、T2WI病灶周围高信号提示RLH而非HCC。
- 联合模型鉴别RLH与HCC的AUC为0.965,敏感度96.8%,特异度83.9%。
- 联合模型优于单独AFP、肿瘤边界或T2WI病灶周围高信号。
关键影像表现/征象
- RLH的MRI特征包括边界不清和T2加权成像病灶周围高信号。
- HCC与RLH的鉴别需结合临床AFP水平及MRI边界和T2WI病灶周围信号特征。
诊断标准与关键数值
- 低AFP、边界不清、T2WI病灶周围高信号为RLH的独立预测特征。
- 联合模型鉴别RLH与HCC的AUC为0.965(95%CI:0.884-0.995),敏感度96.8%(95%CI:83.3%-99.0%),特异度83.9%(95%CI:66.3%-94.5%)。
- 联合模型显著优于单独AFP、肿瘤边界、T2WI病灶周围高信号(P<0.05)。
临床应用与阅片要点
- 对于非肝硬化慢性HBV患者,发现肝脏病灶时应关注AFP水平、病灶边界及T2WI病灶周围高信号,以鉴别RLH与HCC。
- 联合模型可辅助诊断,避免将RLH误诊为HCC而导致不必要的手术。
局限性
- 回顾性研究,样本量较小(每组31例),模型在同一匹配数据集中推导和测试,需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify clinical and MRI features and construct a diagnostic model for differentiating hepatic reactive lymphoid hyperplasia (RLH) from hepatocellular carcinoma (HCC) in non-cirrhotic patients with chronic hepatitis B virus (HBV) infection.
MATERIALS AND METHODS: A retrospective study was conducted including 31 patients with pathologically confirmed RLH and 31 propensity score-matched patients with HCC. Clinical and MRI features were compared between the two groups. Firth logistic regression analysis was performed to identify independent predictors of RLH. Receiver operating characteristic curves were used to evaluate diagnostic performance. This was a patient-based analysis, with the largest lesion per patient included. The model was derived and tested in the same matched dataset.
RESULTS: Low AFP, ill-defined margin, and perilesional hyperintensity on T2-weighted imaging were identified as independent predictive features for differentiating RLH from HCC. The integrated model combining these variables achieved an area under the receiver operating characteristic curve of 0.965 (95% CI: 0.884-0.995), sensitivity of 96.8% (95% CI: 83.3%-99.0%), specificity of 83.9% (95% CI: 66.3%-94.5%). The integrated model significantly outperformed AFP, tumor margin, and perilesional hyperintensity on T2-weighted imaging alone (P < 0.05).
CONCLUSION: Clinical and MRI features, particularly low AFP, ill-defined margin, and perilesional hyperintensity on T2-weighted imaging, are useful for differentiating RLH from HCC in non-cirrhotic chronic HBV patients. The integrated model showed excellent diagnostic performance in this patient-based matched cohort and may help reduce unnecessary surgical intervention.
引用
- Lin Q, Miao G, Wang L, et al. Clinical and MRI features for differentiating reactive lymphoid hyperplasia from hepatocellular carcinoma in non-cirrhotic chronic HBV patients. Eur J Radiol. 2026. PMID: 41950865. doi:10.1016/j.ejrad.2026.112844
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。